Research and Development

The FDA has approved Bayer HealthCare’s oncology pill Stivarga to treat patients with metastatic colorectal cancer (mCRC) whose disease has …

Boehringer Board member Engelbert Tjeenk Willink, responsible for Marketing and Sales of Prescription Medicines, has decided to leave at the …

Vertex Pharmaceutical’s pipeline has been dealt a blow with the abandonment of an investigational hepatitis C compound. The US firm, …

GlaxoSmithKline has announced several changes to its Board and Committee structure. The GSK Board of directors with effect from 1 …

Roche is to locate a new translational clinical research centre in central New York, as part of a shift towards …

Sanofi is to cut 900 jobs in its French operations by 2015 – fewer than expected after widespread speculation this …

Novo Nordisk is investing $100 million into enlarging its R&D facilities in Beijing into a state-of-the-art centre. Located in the …

Credit ratings agency Moody’s believes that the travails of the past few years, when various big-selling drugs went off-patent, are …

The recent news that the Pfizer/J&J Alzheimer’s Disease drug, bapineuzumab (bapi), had failed in critical clinical trials resulted in great …

A round-up of recent developments in the contract research sector, including updates from Covance/GNS, AMRI, Celerion, PPD, INC Research and …

Amgen has announced the appointment of ex-J&J comms leader Ray Jordan to the new position of senior vice president, Corporate …

Ten biopharma companies have formed TransCelerate BioPharma Inc, a not-for-profit organisation using money and personnel from each firm, with a …

Transgene has announced the appointment of Dr Nathalie Adda as chief medical officer. Responsible for medical and regulatory affairs of …

Teva has announced the appointment of Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head …

Boehringer Ingelheim has filed its new lung cancer drug with the EMA. Afatinib is the latest targeted therapy for lung …